BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18679780)

  • 21. Evaluating the gold standard: a review and meta-analysis of the Structured Interview of Reported Symptoms.
    Green D; Rosenfeld B
    Psychol Assess; 2011 Mar; 23(1):95-107. PubMed ID: 21381842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noncredible psychiatric and cognitive symptoms in a workers' compensation "stress" claim sample.
    Sumanti M; Boone KB; Savodnik I; Gorsuch R
    Clin Neuropsychol; 2006 Dec; 20(4):754-65. PubMed ID: 16980260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for malingering in a criminal-forensic sample with the personality assessment inventory.
    Boccaccini MT; Murrie DC; Duncan SA
    Psychol Assess; 2006 Dec; 18(4):415-23. PubMed ID: 17154762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malingering as a categorical or dimensional construct: the latent structure of feigned psychopathology as measured by the SIRS and MMPI-2.
    Walters GD; Rogers R; Berry DT; Miller HA; Duncan SA; McCusker PJ; Payne JW; Granacher RP
    Psychol Assess; 2008 Sep; 20(3):238-47. PubMed ID: 18778160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-validation of the PAI Negative Distortion Scale for feigned mental disorders: a research report.
    Rogers R; Gillard ND; Wooley CN; Kelsey KR
    Assessment; 2013 Feb; 20(1):36-42. PubMed ID: 22855508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relation between symptom validity testing and MMPI-2 scores as a function of forensic evaluation context.
    Wygant DB; Sellbom M; Ben-Porath YS; Stafford KP; Freeman DB; Heilbronner RL
    Arch Clin Neuropsychol; 2007 May; 22(4):489-99. PubMed ID: 17350796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating malingering in contested injury or illness.
    Aronoff GM; Mandel S; Genovese E; Maitz EA; Dorto AJ; Klimek EH; Staats TE
    Pain Pract; 2007 Jun; 7(2):178-204. PubMed ID: 17559488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Base rates of malingering and symptom exaggeration.
    Mittenberg W; Patton C; Canyock EM; Condit DC
    J Clin Exp Neuropsychol; 2002 Dec; 24(8):1094-102. PubMed ID: 12650234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cogniform Disorder and Cogniform Condition: proposed diagnoses for excessive cognitive symptoms.
    Delis DC; Wetter SR
    Arch Clin Neuropsychol; 2007 Jun; 22(5):589-604. PubMed ID: 17485192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An examination of the ECST-R as a screen for feigned incompetency to stand trial.
    Rogers R; Jackson RL; Sewell KW; Harrison KS
    Psychol Assess; 2004 Jun; 16(2):139-45. PubMed ID: 15222810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic utility of the structured inventory of malingered symptomatology to detect malingering in a forensic sample.
    Wisdom NM; Callahan JL; Shaw TG
    Arch Clin Neuropsychol; 2010 Mar; 25(2):118-25. PubMed ID: 20110279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malingering assessment: evaluation of validity of performance.
    Vanderploeg RD; Curtiss G
    NeuroRehabilitation; 2001; 16(4):245-51. PubMed ID: 11790911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive functioning in euthymic bipolar I and bipolar II patients.
    Dittmann S; Hennig-Fast K; Gerber S; Seemüller F; Riedel M; Emanuel Severus W; Langosch J; Engel RR; Möller HJ; Grunze HC
    Bipolar Disord; 2008 Dec; 10(8):877-87. PubMed ID: 19594503
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are exaggerated health complaints continuous or categorical? A taxometric analysis of the Health Problem Overstatement Scale.
    Walters GD; Berry DT; Lanyon RI; Murphy MP
    Psychol Assess; 2009 Jun; 21(2):219-26. PubMed ID: 19485676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for feigned psychiatric symptoms in a forensic sample by using the MMPI-2 and the structured inventory of malingered symptomatology.
    Lewis JL; Simcox AM; Berry DT
    Psychol Assess; 2002 Jun; 14(2):170-6. PubMed ID: 12056079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of a rational malingering test using evoked potentials.
    Zarkowski P; Esparza B; Russo J
    J Clin Neurophysiol; 2007 Oct; 24(5):413-8. PubMed ID: 17912066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for malingering in a correctional setting.
    Norris MP; May MC
    Law Hum Behav; 1998 Jun; 22(3):315-23. PubMed ID: 9631665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Comparability of Structured Interview of Reported Symptoms (SIRS) and Structured Interview of Reported Symptoms-Second Edition (SIRS-2) classifications with external response bias criteria": Correction to Tylicki et al. (2018).
    Psychol Assess; 2019 Jan; 31(1):14. PubMed ID: 30596448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences between Structured Interview of Reported Symptoms (SIRS) and SIRS-2 sensitivity estimates among forensic inpatients: A criterion groups comparison.
    Tarescavage AM; Glassmire DM
    Law Hum Behav; 2016 Oct; 40(5):488-502. PubMed ID: 27077677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.